idarubicin has been researched along with hoe 33342 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belloc, F; Bernard, P; Boisseau, MR; Dumain, P; Lacombe, F; Lopez, F; Reifers, J | 1 |
Boezeman, J; de Witte, TM; Minderman, H; Pennings, AH; Raymakers, RA; Smeets, ME; Vierwinden, G | 1 |
2 other study(ies) available for idarubicin and hoe 33342
Article | Year |
---|---|
Intercalation of anthracyclines into living cell DNA analyzed by flow cytometry.
Topics: Benzimidazoles; Daunorubicin; DNA; Energy Transfer; Flow Cytometry; Fluorescence; Humans; Idarubicin; Intercalating Agents; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured | 1992 |
Idarubicin DNA intercalation is reduced by MRP1 and not Pgp.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Pair Mismatch; Benzimidazoles; Daunorubicin; DNA-Binding Proteins; Energy Transfer; Flow Cytometry; Fluorescent Dyes; Humans; Idarubicin; Intercalating Agents; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; Rhodamines; Sensitivity and Specificity; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1999 |